期刊
EUROPEAN JOURNAL OF RADIOLOGY
卷 86, 期 -, 页码 371-376出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.ejrad.2016.09.014
关键词
Positron emission tomography; COPD; Pulmonary fibrosis; Asthma; (18)Fluorodeoxyglucose; (18)Fluoro-fluciclatide; F-18-NOS
资金
- National Institutes of Health [R01 HL121218, HL116389]
Inflammatory lung disease is one of the most common clinical scenarios, and yet, it is often poorly understood. Inflammatory lung disorders, such as chronic obstructive pulmonary diseases, which are causing significant mortality and morbidity, have limited therapeutic options. Recently, new treatments have become available for pulmonary fibrosis. This review article will describe the new insights that are starting to be gained from positron emission tomography (PET) methods, by targeting molecular processes using dedicated radiotracers. Ultimately, this should aid in deriving better pathophysiological classification of these disorders, which will ultimately result in better evaluation of novel therapies. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据